Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-04-22

Clinical Trial Update: Pharmacogenomics of Methadone in Spine Fusion Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating pharmacogenomics of methadone in spine fusion surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methadone (methadone)

Snippet

Sponsor: Northwestern University | Conditions: Scoliosis, Kyphosis | Phase 1 | Status: WITHDRAWN